BCR-ABL tyrosine kinase inhibitors

Pfizer 400 Pill - orange oval, 18mm

Generic Name: bosutinib

Pill with imprint Pfizer 400 is Orange, Oval and has been identified as Bosulif 400 mg. It is supplied by Pfizer Inc.

Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Bosulif (Bosutinib [ boe-sue-tin-ib ])-Pfizer 400-400 mg-Orange-Oval

Bosulif
Generic Name: bosutinib [ boe-sue-tin-ib ]
Imprint: Pfizer 400
Strength: 400 mg
Color: Orange
Size: 18.00 mm
Shape: Oval
Availability: Prescription only
Drug Class: BCR-ABL tyrosine kinase inhibitors
Pregnancy Category: D - Positive evidence of risk
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00069-0193
Inactive Ingredients: Microcrystalline cellulose, Croscarmellose sodium, Povidone k25, Magnesium stearate, Titanium dioxide, Polyethylene glycol 3350, Magnesium silicate, Ferric oxide red, Poloxamer 188,
Latest News
Related Drugs